Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Stephen Gillett
AddedMar 31, 2024
UpdatedMay 31, 2026
Stephen Gillett

Stephen Gillett

Board Member, Discord

CrunchbaseLinkedIn

Stephen Gillett's Career

Discord
Discord

San Francisco, CA, US

Board Member· Board
Verily
Verily

South San Francisco, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Stephen Gillett's Career

Discord
Discord
Series A$1B4.1k2012San Francisco, CA, US
Board Member· Board

Recent news

Chat platform Discord files confidentially for US IPO, Bloomberg News reportsReuters · 2026
Discord's CEO says he's stepping down, and these 3 major video games are on his backlogYahoo Finance · 2025
Fidelity deepens valuation cut for Reddit and DiscordTechCrunch · 2023

Leadership at Discord

Humam SakhniniHumam SakhniniChief Executive Officer
Mitch LaskyMitch LaskyBoard Member
Peter RelanPeter RelanBoard Member
Josh ElmanJosh ElmanBoard Member
Mark BreedonMark BreedonBoard Member
Jason CitronJason CitronFounder
Verily
Verily
Public$3.5B2k2015South San Francisco, CA, US
Board Member· Board

Leadership at Verily

Andrew ConradAndrew ConradBoard Member
Linda MantiaLinda MantiaBoard Member
Jessica L. MegaJessica L. MegaCo-Founder
Yossi MatiasYossi MatiasBoard Member
Andy ConradAndy ConradCo-Founder

Similar to Verily

Gilead SciencesGilead SciencesFoster City, CA, USPharmaceuticals, Therapiesest. 1987Gilead SciencesFoster City, CA, US · est. 1987

Gilead Sciences: An American biopharmaceutical firm innovating therapies for critical diseases.

Public · $2B17k
DnanexusDnanexusMountain View, CA, USData Analysis, Data Managementest. 2009DnanexusMountain View, CA, US · est. 2009

American firm DNAnexus offers cloud-based DNA sequence data analysis and management.

Series H · $472.6M292
InsitroInsitroSouth San Francisco, CA, USDrug Discoveryest. 2018InsitroSouth San Francisco, CA, US · est. 2018

Insitro: Leveraging machine learning for data-driven drug discovery and development.

Series C · $643M295
Verge GenomicsVerge GenomicsSan Francisco, CA, USDrug Developmentest. 2015Verge GenomicsSan Francisco, CA, US · est. 2015

Verge Genomics accelerates drug development for neuro diseases using AI and human data.

Series B · $134.1M83

Stephen Gillett's Similar Executives & Operators

Soemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao

People Similar to Stephen Gillett

Rodney RogersRodney RogersCo-Founder · Blue Lagoon CapitalChad RichisonChad RichisonBoard Member · Paycom SoftwareHoward P. KernHoward P. KernBoard Member · Sentara HealthcareMichael MontaganoMichael MontaganoBoard Member · Kitchen UnitedErik FyrwaldErik FyrwaldBoard Member · SyngentaGuillaume CeruttiGuillaume CeruttiCEO · Christie's